1992
DOI: 10.1016/s0021-9258(18)42149-7
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1996
1996
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 97 publications
(3 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…Thus, GC effectiveness is determined by several selective tissue- and/or cell-specific components such as GC bioavailability dependent on metabolizing enzymes notably expression of 11beta-hydroxysteroid dehydrogenase, GR splice variants, contents in GR interacting proteins, and chromatin accessibility [ 24 ]. The PAI-1 promoter is known to have, in addition to GRE, response elements for the AP-1 transcription factor complex (Fos:Jun) [ 70 ]. A plausible explanation of the observed dose-dependent effects is that when moderate levels of activated GR are produced, GR/AP-1 heterodimers, which are known to promote reciprocal transcriptional interference, are mostly formed and prevent PAI-1 transcription through a protein–protein interaction mediated-sequestration process [ 71 , 72 ].…”
Section: Discussionmentioning
confidence: 99%
“…Thus, GC effectiveness is determined by several selective tissue- and/or cell-specific components such as GC bioavailability dependent on metabolizing enzymes notably expression of 11beta-hydroxysteroid dehydrogenase, GR splice variants, contents in GR interacting proteins, and chromatin accessibility [ 24 ]. The PAI-1 promoter is known to have, in addition to GRE, response elements for the AP-1 transcription factor complex (Fos:Jun) [ 70 ]. A plausible explanation of the observed dose-dependent effects is that when moderate levels of activated GR are produced, GR/AP-1 heterodimers, which are known to promote reciprocal transcriptional interference, are mostly formed and prevent PAI-1 transcription through a protein–protein interaction mediated-sequestration process [ 71 , 72 ].…”
Section: Discussionmentioning
confidence: 99%
“…PAI-1 can be synthesized and secreted by platelets (Erickson et al, 1985), vascular endothelial cells (Reilly and McFall, 1991), vascular smooth muscle cells (Reilly and McFall, 1991), and several nonvascular cell types (Busso et al, 1994). PAI-1 gene expression can be regulated by a variety of stimuli, including phorbol ester (Descheemaeker et al, 1992), transforming growth factor-b (Sawdey and Loskuto¡, 1991;Song et al, 1998), tumor necrosis factor-a (Sawdey and Los-kuto¡, 1991), interleukin-1 (Bevilacqua et al, 1986), lipopolysaccharide (Crutchley and Conanan, 1986;Sawdey and Loskuto¡, 1991), insulin, and insulin like growth factor-1 (Fattal et al, 1992;Ban¢ et al, 2001), platelet-derived growth factor (Reilly and McFall, 1991), and angiotensin II (Feener et al, 1995;Takeda et al, 2001). Recent studies reported an upregulation of PAI-1 gene expression induced by low oxygen tension (hypoxia) in trophoblast cells (Fitzpatrick and Graham, 1998), hepatocytes (Kietzmann et al, 1999), endothelial cells (Uchiyama et al, 2000), transformed murine macrophages (Pinsky et al, 1998), and some cancer cell lines (Fink et al, 2001).…”
mentioning
confidence: 99%
“…The PAI-1 inhibitors augment tPA and plasmin activity, and significantly lower plasma and brain Ab levels (Jacobsen et al, 2008). The presence of c-Junresponsive elements in the PAI-1 promoter has been reported (it is an AP-1-like binding site; Descheemaeker et al, 1992). However, DHA inhibits AP-1 and suppresses AP-1 activation (transcription factor activator protein 1; Liu et al, 2001;Zgórzyńska et al, 2021) via PPARɣ (Konstantinopoulos et al, 2007;Fig.…”
Section: The Mechanisms Of Bdnf's Actionmentioning
confidence: 99%